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The locations and dynamics of glutamate synaptic receptors—the AMPA receptors 
(AMPARs) and NMDA receptors (NMDARs)—located on the postsynaptic membrane of nerve 
cells, are crucial for neuronal health, learning and memory formation. They can exist under basal 
condition where no synaptic strength change occurs, and chemically induced long-term 
potentiation (cLTP) condition, where synaptic strength is increased by activation of NMDARs 
from glycine that triggers changes in the number and structure of AMPARs. With three-
dimensional super-resolution microscopy (7~16 nm resolution in x-y and 20~32 nm resolution in 
z), we study AMPARs and NMDARs under basal and cLTP conditions.  
Under basal condition, we compare two different size fluorophores attached to AMPAR or 
NMDAR: one is big quantum dots (bQDs), ~20 nm in diameter, which are widely used in the 
literature; the other is organic dyes, which together with its necessary binding protein, are ~ 4 nm 
in diameter. We find that organic dyes are superior to bQDs because organic dyes have better 
access to synapses, which itself is only 20-25 nm across, due to their smaller size.  Our results with 
organics dyes (particularly, Atto647N) are shown to be different than the prevailing results based 
on bQDs. AMPARs are found to be mostly constrained in the synaptic region, which contradicts 
the ‘slots’ hypothesis using bQDs. NMDARs, however, are found in both synaptic and 
extrasynaptic regions. The ratio of synaptic/extrasynaptic population of the two NMDAR subunits 
(GluN2A and GluN2B) are found to be very different. This ratio is known to be significant in 
neuronal function/dysfunction. We also quantified this ratio during the maturation process and find 
redistribution of the synaptic/extrasynaptic NMDARs. 
Next, cLTP is induced. During this process, the activation of NMDARs is known to cause 
changes in number and structure of AMPAR on the postsynaptic membrane. In particular, the 
AMPAR subunits GluA1 and GluA2 are known to contribute to cLTP, but a quantitative 
understanding is missing in terms of the AMPAR insertion sites on the postsynaptic membrane; 
how AMPARs move after insertion; and if there are structural changes of AMPARs upon cLTP. 
We tracked the newly inserted AMPARs and find both synaptic and extrasynaptic insertion sites 
at 5 and 20 min after cLTP. The portion of synaptic AMPAR increases from 5 to 20 min (32% to 
50%). Correspondingly, we also find an increase in synaptic AMPAR numbers. This is done by 
determining the number of AMPARs under basal condition and the number of the newly inserted 
ones at 5 and 20 min after cLTP. Taking GluA1-type AMPAR at 5 min after cLTP as an example, 
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under basal conditions, there are 31.8±1.7 synaptic GluA1 on the membrane; when cLTP is 
induced, 8.1±0.23 internal AMPARs exocytose to the membrane: that is 22.1% ± 1.3% more 
synaptic GluA1 compared to basal level. Repeating the same method at 20 min after cLTP gives 
28.9% ± 1.4% more synaptic GluA1 compared to basal level. This means there is a 7% (out of 
22%) increase in synaptic GluA1 from 5 to 20 min. We determine that this occurs because of 
synaptic exocytosis, not the widely believed lateral diffusion. The conclusion for GluA2 is the 
same. Aside from the number change, we also observe the structure change of AMPAR during 
cLTP. We find a ~1.6x increase in AMPAR channel currents from 5 min to 20 min after cLTP. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
 
1.1 Brain, synapses and receptors: 
The human brain contains 80~100 billions of neurons which form a network to 
communicate with each other. Each neuron connects to 1-10,000 other neurons, though synapses 
(Fig. 1.1). Synapses are important because they mediate almost all signal amplification and 
computation. A typical structure of a synapse is shown in Fig. 1.2: it is composed of pre-synapse, 
synaptic cleft and post-synapses. On the post-synapse, there are receptors and postsynaptic density 
(PSD) proteins which help to stabilize those receptors. AMPA receptors (AMPARs) and NMDA 
receptors (NMDARs) are two key postsynaptic ionotropic glutamate receptors 1 as detailed in the 
next section. They are dynamic on the postsynaptic membrane, and their movements and location 
are important in synaptic plasticity—the ability of synapses to become stronger or weaker in 
response to increase or decreases in their activity—which is important in learning and memory 2. 




Figure 1.1 Neurons form networks in the brain. The structure connecting two neurons is called synapse, which is in 





Figure 1.2 Structure of a synapse. A synapse is composed of pre-synapse from neuron 1, the synaptic cleft between 
the two neurons, and the post-synapse from neuron 2. The signal is transmitted from neuron 1 to neuron 2, i.e., 
information flows from pre-synapse to post-synapse. The neurotransmitter (small red dots) in the synaptic vesicle 
(dotted circle, surrounding the neurotransmitter) diffuses to the presynaptic membrane and can release from into the 
synapse cleft and interact with AMPAR and NMDAR on the post-synapse. AMPAR and NMDAR are anchored on 
the post-synapse membrane by PSD. 
 
1.2 NMDAR and AMPAR: 
NMDARs have four subunits—GluN1, GluN2A ~ D, and GluN3. In the central nervous 
system (CNS), they are majorly di-heterodimers, for example:  GluN1(dimer)/GluN2A(dimer) and 
GluN1(dimer)/GluN2B(dimer), or sometimes tri-heteromers, 
GluN1(dimer)/GluN2A(monomer)/GluN2B(monomer) (Fig. 1.3) 3. In the early stages of neuronal 
development, GluN2B-containing NMDARs expressed predominantly more than GluN2A-
containing ones, whereas GluN2A are more expressed in the later stages 4. This indicates that the 




Figure 1.3. Structure of NMDARs 3.  NMDARs are glutamate receptors composed of two GluN1 and two 
GluN2 or GluN3 subunits. They are permeable to Ca2+, Na+, etc. Glutamate (binds GluN2 subunits) and glycine 
(binds GluN1) can bind activate NMDAR. Then the Mg2+ blockade is released by membrane depolarization 3. 
 
NMDAR mainly controls synaptic activity in neurons, and it is important in nerve cell 
viability 5. The synaptic/extrasynaptic ratio of NMDARs is believed to play an important role in 
neuronal function and dysfunction 6–12. The function of synaptic/extrasynaptic NMDARs has been 
intensively studied over the last decade 7,8,13. For example, activation of synaptic NMDARs 
protects neurons from apoptosis while the activation of extrasynaptic ones would contribute to 
neuronal dysfunction. However, there is very little knowledge of the diffusion and population 
distribution of NMDARs.  
AMPAR is also important in the CNS 1, it mediates the majority of the fast synaptic 
transmission at excitatory synapses 14,15. Under basal conditions, AMPARs predominately locate 
close to the post-synapses and are associated with PSD 14,16. When there is a long-lasting increase 
in synaptic strength—long-term potentiation (LTP)—the lateral diffusion and the new insertion of 
AMPARs on the postsynaptic membrane is believed to play significant roles with the activation 
of NMDARs 15,17,18, which is the cellular basis of learning and memory 17. GluA1 and GluA2 
subunits of AMPAR are also thought to contribute differently to LTP 19. However, the detailed 
process underlying LTP in terms of AMPAR trafficking and insertion still remains unclear due to 
the lack of good probes and methodologies.  
For both AMPAR and NMDAR, traditional electrophysiological method, which measures 
the change of ion current or voltage, has been instrumental in understanding functions and 
regulations of these receptors 20–23. However, this method lacks the ability to directly visualize 
real-time dynamic behavior of receptors. Therefore, it is not possible to measure the diffusion 
using this method. Meanwhile, it is also hard to separate the receptor accretion in the synapses 
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from the enhancement of the receptor activity: for example, increase in opening probability or 
increased channel conductivity. 
Fluorescence method enables direct visualization of the receptors and synapses, which is 
one of the best methods to study the location and diffusion of the receptors 15,19,24–27. However, the 
probes used are either not suitable for super-resolution imaging, for example, SEP (superecliptic 
pHluorin) 19, or too big (bQDs) to enter the synapse 16,25. Therefore, in this work, organic dyes are 
used to study receptors. 
Given the facts stated in the above paragraphs, we are motivated to use super-resolution 
fluorescence imaging method to study the diffusion and synaptic location properties of AMPAR 
and NMDAR (GluN2A and GluN2B) under basal condition, and AMPAR (GluA1, GluA2) under 
chemical LTP (cLTP) condition.  
In this work, we study AMPAR under basal condition to understand whether they are 
synaptic or extrasynaptic. We find AMPARs are largely synaptic. We then study AMPAR under 
LTP condition to understand the LTP process. We find exocytosis at synaptic site (not lateral 
diffusion) and change in structure of AMPARs are important for cLTP. We also further compared 
NMDAR to AMPAR under basal condition to understand their difference. We find NMDARs has 
extrasynaptic nanodomains that AMPAR does not have, which might explain the difference in 
their trafficking. We finally looked at NMDAR under basal condition during maturation to 
understand the maturation process. We find the maturation process include redistribution of 
synaptic/extrasynaptic NMDARs and the decrease of the NMDAR diffusion. Those results will be 





CHAPTER 2: MATERIAL AND METHODS 
 
2.1 Single particle tracking (SPT) and choice of probes: 
Single particle tracking (SPT) is the major technique used in the field to study receptor 
trafficking 24–27. SPT is advanced over the ensemble measurements, for example, FRAP 
15,27(Fluorescence Recovery after Photobleaching), in its ability to detect dynamic behavior of 
individual molecules rather than the averaged of many 43,44 (Fig. 2.1). As shown in Fig. 2.1, there 
are two distinct molecules of interest (rectangle and triangle). At four time points T = 1~4, the 
movements of these two are completely different. SPT can help to track individual movements of 
these two and differentiate the two from each other.  It is important to look at individual behavior 
of a receptor or synapse since individual receptors diffuse differently depending on their synapses 
or locations in the synapses. SPT gives the location information of receptors at every time point. 
Diffusion information can also be extracted from this location information combined with the time 
information.  Therefore, it is advantageous to use this technique when measuring the dynamics of 
individual AMPAR and NMDAR.  
 
Figure 2.1 SPT enables detection of heterogeneity in the system. Two molecules of interest are shown in 
rectangle and triangle. They are labeled with fluorescence probes and therefore can be detected individually. 
 
Another advantage of SPT technique is that it enables doing experiments in live neurons. 
This is important because if the nerve cells are ‘fixed’ (dead), then the diffusion of receptors will 
be biased.  
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In order to detect the movements of AMPARs or NMDARs, it is essential to label them. 
Considering the width of synaptic cleft is only 20-25 nm 45,46, if the labeling probe is too big, then 
the labeled receptors will have problem entering the cleft due to steric hindrance. The actual 
diffusion and location information will therefore be biased. In addition, to measure diffusion, the 
probe needs to be photostable enough to enable ~1 min tracking under laser illumination.  
Quantum dots are known to have excellent photostability, but the commercially available 
quantum dots are usually bigger than 20 nm in diameter, thus, it is named big quantum dots (bQDs). 
When functionalized and attached to receptors, bQDs prevent the receptors from accessing the 
synapse 16,31,47. Therefore, despite their widespread application in studying AMPAR and NMDAR 
dynamics 24–27, it is not suitable in studying AMPAR and NMDARs.  
Organic dyes are small enough, typically 4~5 nm after functionalized 16,48. (The dye itself 
is only about 1 nm in length, but it needs to be attached to a small protein to get it to react to a 
particular part of AMPAR or NMDAR.) Atto647N is one of the organic dyes which is photostable 
for ~ 1 min 16. We had used Atto647N in a recent publication and successfully tracked AMPARs 
under basal conditions 16. Hence, we use this probe for the study of NMDARs under basal 
conditions and AMPAR under LTP conditions. 
 
2.2 Three-dimensional SPT with cylindrical lens: 
The diffusion of receptors is a three-dimensional (3-D) movement. Thus, 3-D SPT is 
needed to acquire x, y and z position of the receptor. 3-D imaging is enabled by adding a cylindrical 
lens between the objective and imaging lens (Fig. 2.2 49). It can asymmetrically defocus the point-
spread-function (PSF) of the fluorescent beads on a coverslip below and above the focal plane 49,50 
(Fig. 2.3). The level of asymmetry is quantified by the width minus height of the PSF. Calibration 
curves are then generated based on the level of asymmetry at different imaging plane using the 
fluorescent beads at different wavelengths: one example is shown in Fig. 2.3. 3-D SPT using 
Atto647N gives position information of receptors over time, with 12 nm lateral resolution and 32 
nm axial resolution (Fig. 2.4). 
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Figure 2.2 Cylindrical lens enables 3-D imaging 49. The cylindrical lens is inserted between objective and 
imaging lens. It creates astigmatism and enables 3-D imaging.  
 
2.3 Three-dimensional PALM:  
3-D SPT described above gives position information of receptors. In order to determine the 
synaptic localization of receptors, it is necessary to know the location of post-synapses. As 
mentioned in the ‘Brain, synapses and receptors’ section, there are PSDs in the synapse, which can 
be used to represent the location of post-synapse. In this study, Homer1c, one type of PSD, is 
attached with a so-called photoactivatable fluorescence protein (paFP), in this case, mGeos, to 
indicate where the post-synapse is.  
 
 
Figure 2.3 Astigmatism created by cylindrical lens and the calibration curve. The PSF at focal plane is the same as 
when there is no cylindrical lens, which is symmetric. When the imaging plane is a little above or below (-800 
nm~800 nm) the focal plane, the PSF becomes asymmetric. The level of asymmetry is quantified by the PSF width 
minus height. A calibration curve is generated based on the level of asymmetry at different imaging plane.  
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Figure 2.4 Resolution of Atto647N in 3-D SPT. Histogram is obtained from particle positions from over 200 frames 
at 50 ms exposure time 
 
As paFP, mGeos can be photoactivated—meaning that it can be quenched to dark state and 
then recovered to bright state. The way to localize mGeos is called Photo-Activated Localization 
Microscopy or PALM 51. In PALM imaging, mGeos is labeled at high density, therefore it is hard 
to resolve the location of each molecule. Then mGeos are quenched to dark state and a small 
portion of mGeos is randomly activated by UV to bright state and emit enough photons for 
detection. The location of mGeos can be localized. This process is repeated for many rounds, the 
position of a small group of mGeos are localized in each round. Eventually the position of mGeos 
are stacked together to reconstruct the location of all the mGeos. Figure 2.5 gives an example of 
regular resolution Homer1c-mGeos and super-resolution Homer1c-mGeos. 3-D PALM is enabled 
by adding cylindrical lens. 
 
Figure 2.5 Example of widefield Homer1c-mGeos (left) and super-resolved Homer1c-mGeos (right) 
 9 
2.4 Coverslip preparation: 
The coverslip is prepared in the following way: 
PLL stock solution: dissolve 5 mg/mL PLL (Sigma) into ddH2O as 50x stock solution 
PLL working solution: the working solution is 0.1 mg/mL, which is 50x dilution of the 
stock solution into ddH2O. The solution is prepared fresh (3 mL/coverslip)  
Day1: 
1. Place the dried 25 mm glass coverslip on clean, large glass petri dish. 
2. Plasma (ozone) clean the coverslip for 5 min. This step is to make the surface 
hydrophilic and allow efficient adsorption of the polymer.  
3. Transfer plasma cleaned coverslips into 6-well dishes inside the sterile hood and let it 
sit for 10 min.  
Note: Make sure to sterilize the outside of the glass petri dish before placing it in the 
hood. 
4. Add 3 mL of PLL working solution to each well and incubate overnight in the sterile 
hood. 
5. Turn on the UV lamp at the end of the day to sterilize the coverslips. 
Day 2: 
1. Wash all coverslips 3 times with ddH2O. 
2. Dilute polystyrene beads 1 in 100 in PBS and sonicate for 1 hour. 
3. Further dilute the solution above 50 times and incubate with coverslip in 6-well 
dishes for 20 min. 
4. Wash coverslips 3 times with ddH2O. 
5. Incubate overnight with PLL. 
Day 3: 
1. Wash all coverslips once with water and then the coverslips are ready for plating 
neurons. 
The point of placing beads on the coverslip is to do stage drift correction for super-





2.5 Hippocampal neuron cell plating and culturing: 
Primary hippocampal (HP) cultures were prepared from E18 rats according to UIUC 
guidelines as previously described 16,31. The protocol for plating neuron is as detailed here: 
SLDS:  
82mM Na2SO4, 30 mM K2SO4, 10 mM HEPES, 10 mM Glucose, 5 mM MgCl2 and 0.001% 
phenol red. Adjust pH to 7.4 with NaOH. Filter and sterilize in Biosafety Hood. Then store at 4 °C. 
Plating Medium (PM):  
50 mL Fetal Bovine Serum (FBS), 11.25 mL 20% glucose in MEM (Sigma), 5 mL sodium 
pyruvate (100 mM stock, Thermo Fisher), 62.5 L GlutaMAX (Fisher Scientific), 5 mL 100X P/S 
(Penicillin-Streptomycin, Corning), 439 mL MEM Eagle's with Earles's BSS w/o L-glutamine 
(Sigma). Mix and Filter sterilize in the Biosafety Hood. Store at 4 °C. 
Maintenance Medium (MM):  
10 mL B27 50X supplement (Invitrogen), 1.25 mL GlutaMAX (Fisher Scientific), 5 mL 
P/S, 484 mL Neurobasal medium w/o phenol red (Thermo Fisher). Mix and Filter sterilize in the 
Biosafety Hood. Store at 4 °C. 
1. Pre-warm the protease solution (3 mg/mL in SLDS, Sigma) and plating medium to 37 °C. 
2. Take out water from the 6-well plate using vacuum, add 1 ml plating medium into each 
well, put 6-well plates in incubator for ~20 min. 
3. Polish 2 glass pipettes with flame for later use (one small and another smaller opening). 
4. Transfer HPs into a 15-mL tube and remove extra SLDS using a plastic pipette.  
5. Add protease solution to HPs. If there are ~4 HPs, add 1 mL protease and incubate in 
incubator for 5 min. If there are 8-10 HPs, add 2 mL protease and incubate in incubator 
for 8 min.   
6. Remove the protease solution. Wash HPs with 3 mL of plating medium twice. Remove 
the plating medium and add 2 mL of fresh plating medium into the tube. 
7. Triturate the digested tissue by pipetting up and down 15 times each with the two polished 
glass pipettes from step 3. 
8. After breaking down the tissue, add enough plating medium to make up total volume of 5 
mL. Take 10 L of solution to hemocytometer to count number of neurons.  
9. Take 6-well plates out of the incubator, remove the plating medium, add 2 mL of fresh, 
pre-warmed plating medium into each well.  
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10. Add 0.2 M cells into each well. Distribute cell evenly. 
11. Put 6-well plates back into the incubator, allow 4-5 hours for cells to adhere to the surface. 
12. Check cell adhesion, take out all the plating medium, add 3 mL of maintenance medium. 
13. On DIV 5, remove 0.75 mL maintenance medium and add 1 mL pre-warmed fresh 
maintenance medium. 
14. On DIV 9, repeat step 13.  
15. Neurons are cultured at 37 °C with 5% CO2 in incubator. 
 
2.6 Neuron transfection and labeling: 
Neurons are usually transfected on DIV 13 using lipofectamine 2000 (for premature neuron 
experiments, transfect on DIV 7). For each 25 mm coverslip, 4 L lipofectamine 2000 is added to 
100 L Neurobasal medium, 1 g of each DNA plasmids (usually up to 4) are added to 100 L 
Neurobasal medium in another tube. Then the solution containing DNA plasmids is mixed with 
medium containing lipofectamine very gently and incubated for 20 min to 40 min. Meanwhile, for 
the 3 mL maintenance medium that the coverslip is in, 1 mL is taken out to a new well and mixed 
with 2 mL freshly warmed-up maintenance medium. The DNA and lipofectamine mixture are then 
added to the rest 2 mL in the old well. Both the old and new wells are put back into the incubator. 
After ~16 hours, the coverslip is transferred from old to new well. Two days after transfection, 
experiments are conducted. Table 2.1 below shows the plasmids combination used for the specific 
experiments. For example, when labeling GluN2A with SA-fluorophore (SA stands for 
streptavidin), GluN2A-AP and BirA-ER are used to attach biotin to GluN2A, it can therefore be 
detected with SA-fluorophore. Homer1c-mGeos plasmid is used to label the PSD proteins 
Homer1c with photoactivatable protein to localize the position of synapse.  
 
 




2.7 Molecular biology: PCR and SubCloning: 
The GluA1-AP plasmid is reconstructed from GluA1-SEP by swapping the SEP sequence 
into the AP sequence (Fig. 2.6). GluA1-SEP is a gift from Robert Malinow (Addgene plasmid # 
24000; http://n2t.net/addgene:24000; RRID: Addgene_24000). The method that we used to change 
SEP into AP in GluA1 is called site directed mutagenesis. The diagram for doing this is shown 
below (Fig. 2.7 from NEB Inc.).  
 
Figure 2.6 Plasmid map of GluA1-SEP and GluA1-AP. The green SEP sequence in GluA1-SEP is replaced 
by the short AP sequence indicated by the arrow in GluA1-AP. 
 
 
Figure 2.7 Diagram for site directed mutagenesis (https://www.neb.com/applications/cloning-and-synthetic-
biology/site-directed-mutagenesis). 
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As shown in the diagram, the first step is to design primers to make the substitution. Primers 
are designed by NEBase Changer Online Tool from NEB Inc (Fig. 2.8). Forward primer is (5’ to 
3’) gcagaaaattgaatggcatgaaGCTAGCCCCAACAATATC, and the reverse primer (5’ to 3’) is 
gcttcaaaaatatcgttcaggccCCTAGGGAAATTGGCACC. 
 
Figure 2.8 Example of the primer design with NEBase Changer 
 
Q5 Site-Directed Mutagenesis Kit (NEB Inc.) is used to make the mutation. Below is the 
detailed protocol: 
1. Mix 12.5 L Q5 Hot Start with 0.25 L forward and reverse primer each (50 mM stock), 
1 L GluA1-SEP (~3 ng) and ddH2O to a total volume of 25 L. This mixture is then 
used for the PCR reaction. 
2. Initiate denaturation at 98 °C for 30 s. 
3. Keep sample at 98 °C for 20 s. 
4. Anneal at 62 °C for 30 s. 
5. 72 °C extension for 4 min. 
6. Repeat step 3~5 for 25 cycles. 
7. Final extension at 72 °C for 2 min. 
8. Hold at 4 °C and ready to use. 
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After PCR, check the product size by running a 0.8% agarose gel. The gel is made by 
dissolving 320 mg agarose powder into 40 mL TAE buffer (40 mM Tris, 20 mM Acetatic Acid, 
1mM EDTA) plus 1X SYBR Safe Stain. The sample is loaded by 6X Gel Loading buffer (NEB 
Inc.), 1kb Ladder DNA (NEB Inc.) is loaded into a separate channel. Gel was run at 120 V for 
40~45 minutes. After this, gel is checked under UV to make sure the size of fragment is correct. 
After verifying the size, KLD reaction is performed under room temperature for efficient 
phosphorylation, intramolecular ligation/circularization and template removal of the product. The 
KLD reaction is done by mixing 1 L PCR product, 5 L KLD reaction buffer, 1L KLD reaction 
enzyme mix, 3 L ddH2O and incubating for 5 min. This product is then amplified with DH5 
Alpha by the following protocol: 
1. Take out DH5 Alpha from -80 °C freezer into ice box for 10 min to thaw it. 
2. Add 5 L of KLD reaction product to DH5 Alpha. 
3. Incubate on ice for 30 min, meanwhile, take SOC medium from refrigerator and warm 
it up to room temperature. 
4. Heat shock the mixture for 30 s and put back on ice for 5 min. 
5. Add 950 L SOC medium and place mixture in the shaker for 60 min at 37 °C. 
6. Plate 80~100 L of the cell on agar plate with correct antibiotic resistance, grow 
overnight at 37 °C. 
7. Check colonies on next day and grow 6~8 colonies overnight with autoclaved LB 
medium (10 g LB Broth Lennox from Fisher dissolved in 500 mL water). 
8. Extracted plasmid with OMEGA Mini Prep kit. The mini prep products are sent to the 
UIUC CORE SEQUENCING FACILITY to confirm the sequence of the product.  
 
2.8 cLTP induction: 
On DIV 15, transfected neurons are transferred to extra-cellular control solution (ECS) and 
incubated for 30 min. ECS contains 125 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 33 mM D-glucose, 
0.1 mM DL-APV (NMDAR blocker), 0.003 mM strychnine (inhibitory glycine receptor blocker), 
0.02 mM bicuculine (GABAa receptor blocker), 0.0005 mM TTX (block action potential), and 25 
mM HEPES, with pH=7.3 32. The toxins (DL-APV, strychnine, bicuculine, TTX) are made into 
stock solution and stored in -80 °C freezer. They are diluted freshly into ECS every time when 
experiment is conducted (Table 2.2). cLTP is induced by treating the cell for 10 min with the same 
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external solution but with glycine (200 M), and without TTX, MgCl2, and DL-APV (GISP 
buffer). Similarly, the toxin is added freshly. Then the cell is brought back to the ESC for the 
measurement at 5 min or 20 min after cLTP. All procedures are done at room temperature. 
  
 
Table 2.2 Toxin dilution from stock to ECS and GISP buffer 
 
2.9 Differentiating surface AMPARs before and after cLTP: 
In order to detect the exocytosed AMPARs due to cLTP, it is important to differentiate the 
surface AMPARs before LTP and the exocytosed AMPARs because of LTP. As described in Table 
2.1, GluA1 or GluA2 are transfected with biotin attached. GluA1 (A2) on the surface (blue) have 
biotin toward the extra-cellular side, which can be saturated by 10 nM SA (Fig. 2.9), or 30 nM 
SA-Cy3b (not shown in Fig. 2.9) before cLTP. Therefore, after saturation, there is no free biotin 
on the surface accessible to SA-dye conjugates. When LTP is induced by glycine, intracellular 
AMPARs (red) move to surface and there are new biotins accessible to SA-dye conjugates, for 
example, SA-Atto647N or SA-Alexa647. In this scheme, surface AMPARs before cLTP are either 
dark (when saturated with SA) or labeled by Cy3b, and AMPARs exocytosed are labeled with SA-
Atto647N, or SA-CF633, or sometimes SA-Alexa647, which can be distinguished from ‘dark’ or 
Cy3b. Hence, post-cLTP AMPARs can be distinguished from pre-cLTP AMPARs. 
This method completely separates the AMPARs before and after cLTP, which is better 
than the pH sensitive form of eGFP (Super Ecliptic pHluorin, SEP) used in previous publication 
19. In the case of SEP, it is attached to AMPARs 15,19,27. The ability to differentiate newly inserted 
AMPARs vs AMPARs originally on the surface depends on the pH sensitivity of SEP. Ideally, 
SEP attached to AMPAR is dark while intracellular and becomes bright when exocytosis of 
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AMPAR happens during LTP. However, SEP is found to be bright sometimes while intracellular 
56, thus, it is hard to only rely on SEP to differentiate surface AMPARs before and after cLTP. 
Furthermore, SEP is not ideal for SPT because it is not photostable enough. Therefore, the method 
used here is better for the purpose of this study. 
The saturation concentration for SA is 10 nM as tested (Fig. 2.10). Neurons are transfected 
with Homer1c-mGeos for synapse, and AMPAR-biotin to test the saturation concentration for SA. 
When incubated with 0.6 nM SA-Atto647N for 5 min, AMPARs are labeled and co-localized with 
Homer1c (Fig. 2.10 A-C). On another neuron with the same transfection, before incubation with 
SA-Atto647N, neurons are incubated with 10 nM SA for 10 min. As a result, SA-Atto647N does 
not label on AMPAR. This means 10 nM SA saturates surface AMPARs.  
 




Figure 2.10 Saturation concentration of SA for pre-LTP surface AMPAR is 10 nM. Neurons are transfected 
with (A) (D) Homer1c-mGeos (green) and AMPAR-biotin. (B) AMPAR-biotin is labeled with SA-Atto647N (red) 
(C) AMPAR-Atto647N signal (red) is strong and co-localize with Homer1c (green) if no SA saturation. (E) After 10 
nM SA saturation, neurons are incubated with SA-Atto647N, but there is no AMPAR-Atto647N signal (F) There is 
no co-localization between Homer1c (green) and AMPAR signal (red), which means 10 nM SA saturates surface 
AMPAR before LTP. 
 
2.10 Counting the ratio between surface AMPARs before and after cLTP: 
Similar to the experiment with SA, 30 nM SA-Cy3b is tested to saturate surface AMPAR 
before LTP (Fig. 2.11). More than 98% of the synapses are saturated by 30 nM SA-Cy3b. The way 
we test the saturation is by transfecting the neuron with Homer1c-mGeos (blue, representing 
synapses) and AMPAR-biotin. Then we incubate 30 nM SA-Cy3b (red) with neuron. Afterwards, 
we incubate neuron with SA-Atto647N to test if there are still AMPAR-biotin available to bind. If 
a synapse has only Cy3b signal, that means the AMPAR-biotin on that synapse are saturated. If a 
synapse has both Cy3b and Atto647N signal, that means the AMPAR-biotin on that synapse are 
not saturated. For ~200 synapses that we looked at, only less than 2% have both Atto647N and 
Cy3b signal, over 98% only have Cy3b signal. Therefore, we conclude that more than 98% of the 
synapses are saturated by 30 nM SA-Cy3b. Over 30 nM SA-Cy3b causes non-specific binding. 
Therefore, 30 nM SA-Cy3b is used here. Similarly, 25 nM SA-CF633 saturates surface AMPARs 
after cLTP (Fig. 2.12). The way we test this is very similar to the test for SA-Cy3b. The reason we 
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use SA-CF633 instead of SA-Atto647N is because SA-Atto647N gives more non-specific binding 
at high concentration before reaching the saturation point as we tested (not shown here).  
 
 
Figure 2.11 30 nM SA-Cy3b saturates surface AMPARs before LTP. Neurons are transfected with AMPAR-biotin 
and Homer1c-mGeos (blue). Neurons are first incubated with 30 nM SA-Cy3b (red) for 10 min, followed by 5 min 
incubation of SA-Atto647N (green). Homer1c-mGeos (blue) and AMPAR-Cy3b (red) co-localize, makes the color 
looks purple or magenta. The point of SA-Atto647N incubation is to test if SA-Cy3b saturates surface AMPAR. No 
co-localization between Cy3b and Atto647N means SA-Cy3b is at saturation concentration. When using 30 nM SA-
Cy3b, more than 98% synapses are saturated, as shown above. 
 
The experiment to count the ratio is done according to the following protocol at room 
temperature: 
1. Warm up ESC and GISP buffer to room temperature and add toxin, mix well. 
2. Incubate neurons with ESC for 30 min to equilibrate the neuron to baseline. 
3. Saturate surface AMPARs with 30 nM SA-Cy3b for 10 min. 
4. Induce cLTP by incubating neurons with 200 M glycine in GISP buffer for 10 min. 
5. Return the neuron to ESC and incubate with 25 nM SA-CF633. Image at 5 min or 20 
min after cLTP. 
6. After incubation, wash out unbound free dyes and start to illuminate 640 nm laser until 
CF633 are fully bleached. Then illuminate 561 nm laser until Cy3b are fully bleached. 
Here the decrease in arbitrary intensity (AI) can be quantified by ImageJ. 
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7. On every day the experiment is conducted. There are two dishes used for calibration to 
know the arbitrary intensity (AI) of SA-Cy3b and SA-CF633 labeled on one receptor 
(unit AI). On one dish, cells are incubated with 20 pM SA-CF633, on the other one, 
cells are incubated with 25 pM SA-Cy3b. The cells with CF633 are bleached with the 
same condition as used in step 6 for CF633. The same is for Cy3b. 
8. The ratio between decrease in AI in step 6 and the unit AI in step 7 gives the number 
of receptors before and after cLTP. 
 
 
Figure 2.12 25 nM SA-CF633 saturates AMPARs exocytosed after cLTP. Neurons are transfected with Homer1c-
mGeos (blue) and AMPAR-biotin. After cLTP, neurons are incubated with 25 nM SA-CF633 (red). Then incubated 
with SA-Cy3b (green) to check for saturation. Over 98% synapses are saturated. More than 25 nM cause non-
specific binding, therefore 25 nM is good enough to use here. Scale bar: 5 m. 
 
2.11 Microscope: 
Experiments were performed with a Nikon Ti Eclipse microscope with a Nikon APO 100 
X objective (N.A. 1.49). The microscope used the Perfect Focus System to keep the sample on 
focus in z-axis. An Agilent laser system MLC400B with four fiber-coupled lasers (405 nm, 488 
nm, 561 nm and 640 nm) was used for laser illumination. NIS-Elements software from Nikon was 
used to acquire data. EMCCD (Andor DU897) was used for recording. A motorized stage from 
ASI with a Piezo top plate (ASI PZ-2000FT) was used for x-y-z position control. A quad-band 
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dichroic (Chroma, ZT405-488-561-640RPC) was used and band-pass emission filters 525/50, 
600/50, 680/40, were used for fluorescence imaging. 
 
2.12 Tracking receptors and PALM imaging of Homer1c-mGeos in live neurons: 
The tracking of receptors (AMPAR or NMDAR) is done base on the following protocol: 
1. Neurons are incubated with 1 mL ESC (for AMPAR under cLTP) or HEPES based 
saline buffer (for NMDAR under basal condition) containing 0.3~0.6 nM SA-
Atto647N, 25 L casein (blocking agent for non-specific binding) for 5 min.  
2. Wash with ESC or HEPES based saline buffer for 3 times and then put sample chamber 
onto the microscope. 
3. Track receptors for 500~1000 frames under 640 nm laser illumination with 50 ms 
exposure time. 
4. Do PALM on Homer1c-mGeos for 500~1000 frames under 488 nm laser illumination 
(50 ms exposure time) and 405 nm laser activation. 405 nm laser is illuminated every 
20~40 frames of 488 nm illumination. 
5. Move to another transfected cell and repeat 3,4. Do this for 3~4 cells and start another 
cell. This is to make sure that cells are healthy while doing the tracking experiment. 
After taking the data, the data analysis is done the same way as previously described 16. 
Locations of molecules in each frame are identified with ImageJ plugin. Then chromatic aberration 
and drift are corrected by customized Matlab code. For the tracking data, a Matlab code was used 
to reconstruct the trajectories of the receptors. It finds locations of receptors at time t, and searches 
for nearby receptors at time t+1 as the next point on the trajectory, the maximum displacement of 
a receptor from t to t+1 is set to be 1 μm to distinguish different receptor trajectories. The trajectory 
range was obtained by calculating the range of the trajectory in the x-, y-, and z- direction, and 
using the maximum of the three parameters. The diffusion coefficients were calculated in Matlab 
by fitting the first 4 points of mean-square-displacement curve. For the PALM data, positions of 
PSD proteins detected in each frame are localized. Then cluster analysis is used to identify 
synapses. The position of Homer1c is determined in order to tell whether receptor is synaptic or 
extrasynaptic by measuring distance between the center of Homer1c and the position of receptor. 
In this study, distance less than 0.5 m is considered synaptic; distance between 0.5 m and 2 m 
is considered extrasynaptic. This agrees with a previous publication 16. VMD 1.9.2 software is 
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used to create the 3-D visualization of the synapses and the receptors 16,57. VMD (Visual Molecule 
Dynamics) is a software developed by Klaus Schulten in UIUC, which is a great software for 
visualizing molecules location and movements in 3-D 16,57. 
 
2.13 Stage Drift correction: 
For super-resolution imaging, stage drift is a major factor that would affect the resolution. 
Here in this study, polystyrene beads are used as fiduciary markers on the coverslip to correct for 
the stage drift. They are plated on coverslip as described in section ‘coverslip preparation’. An 
example of beads spread on the coverslip is shown below in Fig. 2.13: 
 
Figure 2.13 Example of beads on the coverslip 
 
An infra-red (IR) light is used for illumination, and an IR camera is synchronized with the 
EMCCD camera. Therefore, when the EMCCD begins to capture a fluorescent image, the IR 
camera starts at the same time to record the movement of the beads. By subtracting the 
displacement of the beads, the stage drift correction is completed because the movements of beads 
are representative of the stage drift.  
The stage drift correction precision is calculated by taking the difference between traces 
and the averaged traces in x, y and z directions. For example, figure 2.14 shows trace of fours 
beads (right) in x, y and z direction. The histogram is generated by doing frequency count on the 
value from subtracting the averaged trace from the four traces. The standard deviation of the 
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histogram stands for the drift correction precision, which is ~1.4 nm in x and y direction, ~4.6 nm 
in z direction. 
 
Figure 2.14 Traces (right) and drift correction precision (left) in x, y, z direction 
 
2.14 Chromatic aberration correction: 
Chromatic aberration occurs because the lens has different refraction index for dyes that 
emit at different wavelengths. This causes shift in the location of targets under different 




Figure 2.15 Nanohole used for chromatic aberration correction.  
 
In Fig. 2.15, the nanohole is taken under green (GFP) and red (RFP) channel. This image 
is used for creating the mapping function between the green and red channel. The location of 
molecules in the red channel is corrected to the green channel. For the 640 nm channel, a similar 
image is used to transform locations in the 640 nm channel to the green channel. The uncertainty 
for this chromatic correction is less than 2 nm 58–60. 
 
2.15 Electrophysiology and Data acquisition on AMPARs: 
The increase in postsynaptic currents after cLTP is related with number and structure 
change of AMPARs. To study the structure change in AMPAR during cLTP. We want to compare 
the number of newly inserted AMPARs and the current after cLTP. The electrophysiology is done 
by Sung-Soo Jang, a graduate student and collaborator in Prof. Hee Jung Chung’s group. Whole-
cell patch clamp recordings of mEPSCs (miniature excitatory synaptic currents) were performed 
at 23–25°C from pyramidal neurons held at -60 mV using a Multiclamp 700B amplifier, 
Digidata1440A, and the pClamp 10.2 (Molecular Devices). Cells were visualized with an upright 
microscope with infra-red differential interference contrast (IR-DIC) optics. Recording pipettes 
were pulled from glass capillaries (World Precision Instruments), they had a resistance of 4-6 MΩ 
when filled with internal solution containing (in mM): 130 K-gluconate, 10 KCl, 10 HEPES/K-
HEPES, 2MgSO4, 0.5 EGTA, and 2 ATP (pH 7.3, 285-295 mOsm). The recording chamber was 
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perfused with ACSF (Artificial cerebrospinal fluid) at 1~1.5 ml per min. For chemical LTP 
experiments, neurons were pre-incubated for 5 min in ECS. cLTP was induced by treating the 
GISP buffer to primary cultured neurons for 3 min. After glycine treatment, cultures were returned 
to the control solution. The mEPSCs were acquired 3 min after making the whole-cell 
configuration, filtered at 1 kHz, and sampled at 10 kHz on gap free model (5 min). All events of 
mEPSCs were detected with 10 pA thresholds and analyzed Mini Analysis (Synaptosoft). Data are 
presented as means ± SEM, statistical analyses were performed with Origin 9.1 (Origin Lab). The 
one-way ANOVA with Tukey’s and Fisher’s multiple comparison tests were performed to identify 
the statistically significant difference with a priori value (p) < 0.05 between 2 groups and for > 3 
groups, respectively. Note that the baseline and glycine treatment time is shorter than when taking 
fluorescence measurement, this is because with the whole-cell configuration, the cell is patched 
and therefore, the total measurement time is limited to make sure cell is healthy during mEPSCs 
recording. 
 
2.16 Immunoblot analysis 
The immunoblot analysis is also done by Sung-Soo Jang.  
Lysate samples from primary hippocampal neurons in groups of control and cLTP are 
prepared in RIPA buffer supplemented with protease inhibitor and Tyr phosphatase inhibitors (1 
mM NaVO3, 10 mM Na4O7P2, and 50 mM NaF) as described. Neuronal lysates are run on SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) gels and transferred to polyvinyl difluoride 
(PVDF) membrane. The blots are blocked in 5% milk and 0.1% Tween-20 in Tris buffered saline 
(TBS) for 1 h and then incubated in primary antibodies against phospho-CaMKII (#3362, Cell 
Signaling, 1:1000), CaMKII (#3362, Cell Signaling, 1:1000), and GAPDH (#2118, Cell Signaling, 
1:1000). After incubating in HRP-conjugated secondary antibody in washing buffer for 1 h, the 
blots are exposed to enhanced chemiluminescence substrate (ECL, Thermo Fisher Scientific) for 
1 min. The luminescent signals are detected by exposing the blots to X-ray films, which are then 
developed with a Kinica SRX- 101A film processor. Densitometric quantification is performed 
with Image J Software (National Institute of Health).   
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CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 AMPAR under basal condition:  
Summary: 
The question of AMPAR being synaptic or extrasynaptic has always been in debate in the 
field. It is important to answer this question to understand how AMPARs enter the synapses. Here 
we find bQDs cause measurement bias due to its large size when attached to AMPAR. And the 
measurement with smaller probe Atto647N finds that AMPARs are largely synaptic (77%), which 
is against the prevailing ‘slots’ hypothesis. 
 
3.1.1 Atto647N (organic dye) is superior to bQDs in studying AMPARs: 
According to the recent publication from our group 16, bQDs give biased results in 
measurements of the AMPAR diffusion behavior compared to Atto647N.  Only 5% of bQDs 
labeled AMPARs are synaptic (Fig. 3.1), the remaining are extrasynaptic; while using Atto647N, 
77% of Atto647N labeled AMPARs are synaptic (Fig. 3.1), the remaining are extrasynaptic. The 
way to determine synaptic/extrasynaptic is as described in the ‘Material and Methods’: we measure 
the distance between AMPAR and the center of synapse, if this distance is less than 0.5 μm, then 
AMPAR is synaptic; if the distance is within 0.5~2 μm, then AMPAR is extrasynaptic. This 
comparison between the Atto647N and bQDs suggests bQDs experience steric hindrance and, 
therefore, organic dyes like Atto647N are superior to bQDs in studying AMPARs.  
 
3.1.2 AMPARs have high percentage (77%) of synaptic population: 
With Atto647N, we find 77% AMPARs are constrained in synaptic nanodomains (as 
described in introduction, region that is 200-400 nm in sized), and the remaining 23% are freely 
diffusing on extrasynaptic membranes 16 (Fig. 3.2). This is against the ‘slots’ hypothesis given by 
bQDs 61. In the ‘slots’ hypothesis, AMPARs are not stabilized within PSDs until ‘slots’, defined 
as PSD place-holders for AMPARs become free inside the PSD (Fig. 3.3) 16. This hypothesis 
requires large extrasynaptic pools of AMPARs, which is not observed with Atto647N (and 




Figure 3.1 Summary of AMPAR with organic dyes and big Qdots (bQDs) 16. Synaptic AMPARs are 5% with bQDs, 
77% with Atto647N 
 
 
Figure 3.2 With Atto647N, 77% AMPARs are synaptic and in the nanodomain (red dotted circle, typically 200~400 
nm in size). On the left side, that is an example of post-synapse represented by Homer1c-mGeos and the diffusion 
trace of AMPAR around it. Different color stands for different time point of the measurement. Blue stands for early 
time point of measurement, and yellow stands for later time point of the measurement. The remaining 23% are 
extrasynaptic and freely diffusing, with diffusion range over 0.79 µm. On the right side, that is an example of 




Figure 3.3 Schematic of ‘slots’ hypothesis. AMPARs are largely extrasynaptic, the synaptic AMPARs are 
with ‘slots’. Only when a slot is ready in the synaptic region, the extrasynaptic AMPAR will become synaptic. 
 
3.2 NMDAR under basal condition: 
Summary: 
An important process under basal condition is neuronal maturation. GluN2A and GluN2B 
type NMDARs have changes in their numbers during maturation, therefore, they are thought to 
play important roles during this process. In this section, we study the location and movements of 
NMDARs under basal condition in premature (9 days after plated on coverslip) and mature (15 
days after plated on coverslip) neurons to understand changes in the localization and diffusion of 
GluN2A- and GluN2B-type NMDARs during maturation. We find that the maturation process 
includes redistribution of synaptic and extrasynaptic NMDARs, as well as the decrease in 
NMDAR diffusion.  
In mature neurons, the synaptic and extrasynaptic ratio of NMDAR is very important in 
maintaining neuronal health and death 6-9. In particular, the synaptic NMDAR is believed to be 
crucial for neuronal health, and the extrasynaptic NMDAR is believed to play a significant role in 
neuronal death 6-9. Therefore, we compared the synaptic/extrasynaptic population for GluN2A- 
and GluN2B-type NMDARs. We find synaptic/extrasynaptic ratio is different for GluN2A and 
GluN2B, which indicates their different roles in maintenance of neuronal health.    
We also compared NMDAR to AMPAR in mature neurons under basal condition. We find 
extrasynaptic nanodomains for NMDARs which AMPAR does not have. This might explain the 
difference in AMPAR and NMDAR regulation during neuron maturation or LTP. 
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3.2.1 Atto647N (organic dye) is superior to bQDs in studying NMDARs: 
Neurons are transfected with NMDAR-biotin and Homer1c-mGeos and the biotin is 
labeled with SA-bQDs or with SA-Atto647N. As mentioned above, Homer1c is the PSD protein 
indicating the location of a synapse. The distance between the receptors and the center of Homer1c 
is then calculated. By comparing the two measurements with each other, the measurement 
confirms that bQDs decrease the synaptic accessibility of receptors due to steric hindrance (Fig. 
3.4). With bQDs (>20 nm in diameter after conjugated to SA) 62, 45% GluN2A are synaptic (<0.5 
m from Homer1c cluster center) (Fig. 3.4 A). However, with Atto647N (~4 nm in diameter after 
conjugated to SA 16,48), the synaptic GluN2A becomes 73% (Fig. 3.4 B). Similarly, for GluN2B, 
the synaptic GluN2B increases from 43% to 60% while switching from SA-bQDs to SA-Atto647N 
(Fig. 3.4 C and D). This suggests bigger size probes (bQDs) have steric hindrance compared to 
smaller probes (Atto647N) when labeled on GluN2A and GluN2B. Therefore, Atto647N is 
superior to bQDs in studying GluN2A and GluN2B because it has better access to synaptic regions 
and cause less bias.  
 
Figure 3.4 Frequency count histogram of the distance between synapse and the receptor. X axis is the distance (m), 
and Y axis is the normalized frequency count. Red color histogram is GluN2A, and green color histogram is 
GluN2B. Synaptic region is less than 0.5 m from the center of Homer1c, extrasynaptic region is 0.5~2 m from the 
center of Homer1c. (A) 45% GluN2A-SA-bQDs are synaptic, 55% are extrasynaptic (B) 73% of GluN2A-SA-
Atto647N are synaptic, 27% are extrasynaptic (C) 43% GluN2B-SA-bQDs are synaptic, 57% are extrasynaptic (D) 
60% GluN2B-SA-Atto647N are synaptic, 40% are extrasynaptic. 
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3.2.2 Redistribution of NMDARs between extrasynaptic and synaptic region as neurons 
become mature: 
GluN2A and GluN2B are important in neuronal maturation because of their population 
change during the maturation process 28-30. To understand how NMDAR location changes during 
maturation, the distance between NMDARs and Homer1c is measured in premature neurons (DIV 
9) and mature neurons (DIV 15). The synaptic portion for both GluN2A- and GluN2B-containing 
NMDARs are found to increase as neurons grow mature when comparing the histogram of distance 
between Homer1c and NMDARs in mature and premature neurons (Fig. 3.5). In detail, for 
GluN2A-containing NMDARs, 62% are synaptic in premature neurons and the synaptic 
population in mature neurons is 88% (Fig. 3.5 A). This indicates a redistribution of GluN2A-type 
NMDARs between extrasynaptic and synaptic areas as neurons become mature. For GluN2B-
containing NMDARs, 45% are synaptic in premature neurons and 60% are synaptic in mature 
neurons (Fig. 3.5 B). Similar to GluN2A, this indicates a redistribution of GluN2B-type NMDARs 
between extrasynaptic and synaptic areas as neurons become mature. (The localization 
measurement on GluN2A in premature neurons is done with GBP-Atto647N, to compare the case 
in mature neurons, I also used localization result with GBP-Atto647N here in mature neurons, not 
the SA-Atto647N result used in the section above). The redistribution of GluN2A and GluN2B 
from extrasynaptic site to synaptic site indicates significant roles of these two subunits in the 
process of synaptic maturation. 
To make sure the measurement with Atto647N here is valid, CF633, another fluorophore 
claimed to have less non-specific binding than Atto647N 63 is used to measure synaptic population 
of mature GluN2A- and GluN2B-containing NMDARs. The synaptic GluN2A-containing 
NMDAR population is almost the same when GBP-Atto647N (88%) or GBP-CF633 (86%) is used 
(Fig. 3.5 red in A vs Fig. 3.5 C). Meanwhile, the synaptic population for GluN2B is very similar 
when SA-Atto647N or SA-CF633 is used (Fig. 3.5 green in B vs Fig. 3.5 D). By comparing the 
result given by Atto647N and CF633, it confirms that the synaptic/extrasynaptic population 
observed in mature neurons is true. This also means the comparison between mature and premature 
neurons using Atto647N is valid. 
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Figure 3.5 Distance between GluN2A (or GluN2B) and synapses in mature and premature neurons. It is calculated 
between location of receptor and center of Homer1c cluster. X axis is the distance (m), and Y axis is the 
normalized frequency count. Synaptic region is less than 0.5 m from the center of Homer1c, extrasynaptic region is 
0.5~2 m from the center of Homer1c. (A) Red: 88% GluN2A-GBP-Atto647N in mature neurons are synaptic, 12% 
are extrasynaptic; Blue: 65% GluN2A-GBP-Atto647N in premature neurons are synaptic, 35% are extrasynaptic (B) 
Green: 60% GluN2B-SA-Atto647N in mature neurons are synaptic, 40% are extrasynaptic. Purple: 45% GluN2B-
SA-Atto647N in premature neurons are synaptic, 55% are extrasynaptic. (C) In mature neurons, 86% GluN2A-GBP-
CF633 are synaptic, 14% are extrasynaptic (D) In mature neurons, 58% GluN2B-SA-CF633 are synaptic, 42% are 
extrasynaptic. (C) and (D) use another different organic fluorophore CF633 and repeat the results by Atto647N on 
mature neurons. 
 
3.2.3 GluN2A and GluN2B diffuse 2X slower as neurons become mature for different reasons: 
As stated in the last section, GluN2A and GluN2B are important in neuronal maturation. 
To show different roles of GluN2A and GluN2B during maturation, diffusion dynamics (diffusion 
coefficient and trajectory range) of GluN2A and GluN2B are quantified in premature and mature 
neurons with Atto647N (Table 3.1). The diffusion coefficients for both sub-types decrease 
significantly (~2x) as neuron becomes mature. However, they are found to decrease with different 








Table 3.2 Diffusion coefficient of the slow and fast GluN2A and GluN2B in premature and mature neurons 
 
To understand how GluN2A diffuse ~2x slower during maturation, we compared changes 
in the slow (D<0.018 m2/s) and fast (D>0.018 m2/s) GluN2A during maturation, where D stands 
for diffusion coefficient. For GluN2A, by looking at the distribution of the diffusion coefficients, 
in premature neurons there are 77% slow GluN2A (D<0.018 m2/s) and 23% (D>0.018 m2/s) 
fast GluN2A (Fig. 3.6 A); when neurons become mature, there are 93% slow GluN2A and 7% fast 
GluN2A (Fig 3.6 C). The slow GluN2A population increased 16% as neurons become mature. 
Meanwhile, as shown in Table 3.2, the slow GluN2A also become significantly slower for mature 
neurons (t test, t=0.001). Therefore, the reason for the decrease in GluN2A diffusion coefficient 
over maturation is the increase in slow GluN2A population and decrease in slow GluN2A diffusion 
rates.  
Similar to GluN2A, for GluN2B, to understand how GluN2B diffuse ~2x slower during 
maturation, we compared changes in the slow (D<0.018 m2/s) and fast (D>0.018 m2/s) GluN2B 
during maturation. Like what we did for GluN2A, 11% increase (93%-82%) in slow GluN2B is 
observed from Fig. 3.6 B and 3.6 D. However, the slow GluN2B’s diffusion coefficient does not 
significantly change during maturation. The fast GluN2B becomes significantly slower as neurons 
become mature (t test, t=0.001). Therefore, the reason for the decrease in GluN2B diffusion 
coefficient over maturation is the increase in slow GluN2B population and decrease in fast 
GluN2B diffusion rates.  
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The results with GluN2A and GluN2B show ~2x decrease in diffusion for GluN2A and 
GluN2B with different mechanisms when neurons become mature. For GluN2A, the mechanism 
is the increase in slow GluN2A population and decrease in slow GluN2A diffusion rates; For 
GluN2B, the mechanism is the increase in slow GluN2B population and decrease in fast GluN2B 
diffusion rates. This suggests GluN2A and GluN2B play distinct roles during neuronal maturation.  
 
 
Figure 3.6 Heat map of diffusion coefficient and trajectory range for GluN2A and GluN2B in premature and mature 
neurons. X axis is log of diffusion coefficient (log of m2/s), Y axis is the log of trajectory range (log of m). 
Diffusion coefficient less than 0.018 m2/s is slow diffusion, faster than 0.018 m2/s is fast diffusion 16,31. Trajectory 
range less than 790 nm is short trajectory range, bigger than 790 nm is long trajectory range 16,31. (A) In premature 
neurons, there are 77% slow GluN2A with peak value at 10-2.53±0.06 µm2/s and 23% fast GluN2A. 54% are in the 
nanodomain of 200~400 nm and 46% are not in a nanodomain. (B) In premature neurons, there are 82% slow 
GluN2B with peak value at 10-2.44±0.02 µm2/sand 18% fast GluN2A. 59% are in the nanodomain of 200~400 nm and 
41% are not in a nanodomain. (C) In mature neurons, there are 93% slow GluN2A with peak value at 10-2.52±0.05 
µm2/s and 7% fast GluN2A. 67% are in the nanodomain of 200~400 nm and 33% are not in a nanodomain.  (D) In 
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Figure 3.6 (cont.) mature neurons, there are 93% slow GluN2B with peak value at 10-2.57±0.03µm2/s and 7% fast 
GluN2B. 68% are in the nanodomain of 200~400 nm and 32% are not in a nanodomain. 
 
3.2.4 Synaptic/extrasynaptic population of GluN2A and GluN2B in mature neurons (DIV 
15): 
The synaptic/extrasynaptic population of NMDARs in mature neurons is significant in 
maintaining neuronal health 6-9. With Atto647N, significant difference is observed between 
GluN2A and GluN2B in terms of their synaptic placement (Fig. 3.4 B and D) in mature neurons 
(DIV 15). The frequency count histogram shows broader distribution of distances for the GluN2B 
subunit than for the GluN2A subunit. More specifically, when using Atto647N as the probe, 
GluN2B-containing NMDARs have 60% synaptic vs 40% extrasynaptic population, while 
GluN2A-containing NMDARs have 73% synaptic vs 27% extrasynaptic population (Fig. 3.4 B 
and D). The synaptic/extrasynaptic ratio for GluN2A is ~3:1, and for GluN2B, the ratio is ~3:2. 
There are significantly (done by t test) higher (13% more) extrasynaptic GluN2B than GluN2A. 
The shift of GluN2B-containing receptors to longer distance indicates different functions between 
GluN2A- and GluN2B-type NMDARs in maintenance of neuronal function and dysfunction 6–9. 
 
3.2.5 NMDAR vs AMPAR: Extrasynaptic nanodomains of NMDAR that AMPAR lacks: 
For the NMDARs in mature neurons discussed in the above section, we find both synaptic 
and extrasynaptic nanodomains. We split synaptic and extrasynaptic NMDARs based on their 
distance to Homer1c (<0.5 µm being synaptic, 0.5~2 µm being extrasynaptic), and then quantify 
the diffusion trace range for synaptic and extrasynaptic NMDARs separately. The diffusion ranges 
for synaptic and extrasynaptic NMDARs are shown in Fig. 3.7. For GluN2A (Fig. 3.7A, 3.7C), 
with Atto647N, 71% of the synaptic GluN2A are in the nanodomain (Fig. 3.7A); 58% of the 
extrasynaptic GluN2A are in the nanodomain. This shows evidence of both synaptic and 
extrasynaptic nanodomains for GluN2A-type NMDARs. Similarly, for GluN2B, we also find both 
synaptic and extrasynaptic nanodomains (Fig. 3.7 B, 3.7D).  
The presence of NMDAR extrasynaptic nanodomains is different than for AMPAR. 
AMPARs are largely in synaptic nanodomains, and the extrasynaptic AMPARs are freely diffusing 
16. There is no AMPAR extrasynaptic nanodomains. The extrasynaptic NMDAR nanodomains are 
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very important because they might play an important role in regulating NMDARs during synaptic 
maturation 67 or synaptic potentiation 68. 
 
Figure 3.7 Frequency count histogram of the (A)(B) synaptic and (C)(D) extrasynaptic NMDAR trajectory range for 
GluN2A and GluN2B labeled with Atto647N. X axis is the log of trajectory range (m). Y axis is the frequency 
count. Trajectory range less than 790 nm is short trajectory range, bigger than 790 nm is long trajectory range 16,31. 
There are two major populations in each graph. One population is with 200~400 nm trajectory range, which are 
receptors that are in nanodomains. The other population is with ~1 m trajectory range, which are receptors that are 
freely diffusing (not in a nanodomain). (A) 71% synaptic GluN2A-Atto647N are in the nanodomain, 29% are freely 
diffusing. (B) 70% synaptic GluN2B-Atto647N are in the nanodomain, 30% are freely diffusing. (C) 58% 
extrasynaptic GluN2A-Atto647N are in the nanodomain, 42% are freely diffusing. (D) 62% extrasynaptic GluN2B-
Atto647N are in the nanodomain, 38% are freely diffusing. 
 
 
3.3 AMPAR under LTP (cLTP) condition: 
Summary: 
To understand learning process, we studied AMPAR (GluA1 and GluA2 as mentioned 
above) under LTP condition to see what happens after inducing chemical LTP (cLTP, the LTP 
process induced by adding chemical glycine). We find both synaptic and extrasynaptic insertion 
sites for AMPAR at 5 and 20 min after inducing cLTP. We also find the synaptic AMPAR 
increases from 5 to 20 min. The increase is due to exocytosis at synaptic sites, not the widely 
believed lateral diffusion from extrasynaptic sites. AMPARs go from internal sites into synaptic 
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sites, either directly through the internal PSD or, we think more likely, by avoiding the internal 
PSD and then going onto the synaptic membrane. Furthermore, we find that change in structure of 
AMPARs are important for cLTP, contributing significant extra current.  
 
3.3.1 Verification of the cLTP protocol in primary hippocampal cultured neurons: 
It has been established that the application of glycine, the NMDAR co-agonist, leads to 
cLTP of mEPSCs in primary dissociated cultures of hippocampal neurons 32. In this study, to test 
whether glycine treatment induces cLTP under our experimental condition, the whole-cell patch 
clamp is made with pyramidal neurons under primary cultured condition. This is done by 
collaborator Sung-Soo Jang from Prof. Hee Jung Chung’s lab.  
For details of the measurements: mEPSCs are measured with the holding potential of – 60 
mV. After 5 min of stable baseline mEPSCs recording (in ECS), 200 µM glycine (in GISP buffer) 
significantly increases the amplitude of mEPSCs (Fig. 3.8 C, baseline = 16.76 pA ± 0.71; 0 min = 
16.79 pA ± 1.14; 5 min = 19.99 pA ± 1.47; 20 min = 23.23 pA ± 2.69; * p < 0.05, compared with 
baseline, ANOVA test). Meanwhile, the control neuron in ECS is not found to have significant 
change in the amplitude of mEPSCs (Fig. 3.8 B, baseline = 16.84 ± 0.54; 0 min = 17.31 ± 0.61; 5 
min = 16.57 ± 0.29; 20 min = 17.14 ± 1.43; * p < 0.05, compared with baseline, ANOVA test). 




Figure 3.8. Glycine incubation (200 μM, 3 min) potentiates the amplitude of mEPSCs in primary hippocampal 
neurons. (A) Schematic of chemical LTP protocol for this recording. Whole-cell patch clamp is made with cultured 
hippocampal neurons (DIV 15) and mEPSCs are recorded for 5 min as baseline. GISP buffer with glycine (200 μM) 
is treated for 3 min to trigger cLTP (ECS only for 3 min under control condition). After glycine treatment, neurons 
are returned to the ECS for 0, 5, 20 min. (B) (C) Representative traces, plots, and graphs show quantification of the 
amplitude in mEPSCs at baseline, 0, 5, and 20 min after the treatment of (B) control and (C) glycine. Statistical 
significance is determined using ANOVA. n = 10, *p < 0.05. 
 
Another verification that is done to make sure LTP is induced by glycine treatment in our 
experiment condition is to measure phosphorylated CaMKII (pCaMKII). The western blot is also 
conducted by collaborator Sung-Soo. The increase of pCaMKII (Fig. 3.9 B) indicates glycine 
treatment induces LTP 66, which again, confirms our protocol works. 
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Figure 3.9. Increased the level of phospho-CaMKII (pCaMKII) after cLTP induction in primary hippocampal 
neuron culture. (A) Schematic of cLTP protocol. After glycine treatment, cultures were returned to the control 
solution for 0, 5, and 20 min. (B) Representative blots and graphs show quantification of the ratio of pCaMKII, 
CaMKII, and pCaMKII/CaM normalized to control (CTL). pCamKII significantly increased compared to baseline 
under cLTP condition. CaMKII does not have significant change. The ratio of pCamKII over CaMKII also 
significantly increased after cLTP. Statistical significance is determined using ANOVA. n = 7 *p < 0.05, **p < 0.01. 
 
3.3.2 Visualization of cLTP via fluorescence on a single synapse: 
After validation of the cLTP protocol with electrophysiology and western blots, it is 
applied on neurons to visualize cLTP on single synapses basis (Fig. 3.10). By comparing synapses 
on the same neuron before (Fig. 3.10 B) and after cLTP (Fig. 3.10 C), insertion of AMPARs after 
cLTP is clearly observed. Fig. 3.10 B is taken after step (iii) before cLTP (step iv), green color is 
Homer1c-mGeos, which represents synapse. Due to the SA saturation in step (iii), there is no co-
localization between Homer1c and AMPAR. After cLTP, in the exact same region, neurons are 
incubated with SA-Atto647N again. Co-localizations between AMPARs and Homer1c are 
detected, due to cLTP-mediated AMPAR insertion on the membrane (red color in Fig. 3.10 C). 
This confirms the previous published work that AMPAR insertion happens after chemical LTP. 
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Figure 3.10 Visualization of cLTP on single synapses basis. (A) cLTP experiment sequence. (B) (C) Cultured 
hippocampal neurons transfected with Homer1c-mGeos (green) and AMPAR-biotin labeled with SA-Atto647N 
(red). (B) After step (iii), surface AMPR-biotin are saturated by 10 nM SA (step ii), before cLTP, no SA-Atto647N 
labeled on neuron. This image is called image ‘before cLTP’ (C) After cLTP, on the same neuron, SA-Atto647N 
labeled on exocytosed AMPAR due to cLTP. This image is called image ‘after cLTP’. 
 
To make sure the increase in Atto647N signal is due to cLTP-mediated AMPAR insertion, 
not the AMPAR exocytosis that could happen under baseline condition, we did control experiment 
without adding glycine. We find that the baseline control (without glycine) shows no insertion of 
AMPARs (Fig. 3.11). In Fig 3.11, the red signal stands for newly inserted AMPAR. By comparing 
the red signal in Fig. 3.11 A and B, it is clear that the cLTP-mediated AMPAR insertion is the 




Figure 3.11 cLTP -mediated AMPAR insertion is the major source of increase in Atto647N signal. Left: LTP; right: 
baseline control, where no LTP in induced. The LTP mediated AMPAR insertion is the predominant event by 
comparing these two images. 
 
3.3.3 GluA1- and GluA2-type AMPARs differently contribute to cLTP: 
GluA1 and GluA2 are known to contribute to cLTP but lack quantification 19. Increase in 
surface GluA1- and GluA2- sub-types at 5 min and 20 min after cLTP is quantified here. It is 
represented by the ratio between the number of inserted AMPARs after cLTP and the number of 
AMPARs on the membrane before cLTP on the same synapse. For GluA1, we find 31.81.7 
GluA1 at basal level (Fig 3.12 A), and 5 min after cLTP is induced, 8.10.23 more GluA1 inserted 
on the membrane through exocytosis: that is 22.1%2.8% more GluA1 is inserted compared to 
basal level GluA1 numbers. We do the same calculation at 20 min after inducing cLTP and find  
28.9%1.4% more AMPAR inserted compared to basal level GluA1 numbers (Fig. 3.12 B). For 
GluA2, these two numbers are 15.5%0.3% and 20.5%0.3% respectively (Fig. 3.12 C and D). 
By comparing the increase in numbers of receptors for different sub-types at the same time points 
after cLTP, ~ 8% higher increase in GluA1 is found (22.1% vs 15.5%, and 28.9% vs 20.5%). This 
means on the active synapses, GluA1 has stronger response to cLTP compared to GluA2. This 
agrees with the previous results 19. This also suggests different roles that the two sub-types are 






Figure 3.12 GluA1 and GluA2 differently contribute to cLTP. (A) (B) Number of pre- and post-cLTP GluA1-type 
AMPARs and ratio between before and after cLTP at (A) 5 min and (B) 20 min. (C) (D) Number of pre- and post-
cLTP GluA2-type AMPARs and ratio between before and after cLTP at (C) 5 min and (D) 20 min. 
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3.3.4 Structure changes of AMPARs after cLTP: 
Increase in the number of AMPARs and the corresponding increase in mEPSCs after cLTP 
is compared (Table 3.3) to show the changes in structure of AMPARs. From 0 min (baseline) to 5 
min after cLTP (early stage), the increase in mEPSCs is 25% and the increase in number of GluA1 
on the membrane is 22.1% (or 15.5% for GluA2). From 5 min to 20 min (late stage), the increase 
in mEPSCs becomes 50% but the increase in the number of inserted GluA1 is only 28.9% (or 20.5% 
for GluA2). If the increase in mEPSCs is purely by the increase in number of GluA1 (or GluA2), 
at 20 min after inducing cLTP, the number increase of GluA1 should be around 44% or 31% for 
GluA2. However, in this case, the number increase of AMPARs is 28.9% (GluA1) or 20.5% 
(GluA2), which is ~1.6x less than expected. This suggests a ~1.6x increase in AMPAR ion channel 
currents at the late stage to compensate for the reduced increase in the number of AMPARs. The 
increase in ion channel currents could be a combined result of the increase in opening probability 
and conductance of the ion channels, which could be a result of structure change. The reason for 
this structure change is not clear yet, but it could be desensitization. 
 
 
Table 3.3 Summary of increase in mEPSCs and number of AMPARs at 5 min and 20 min after cLTP. According to 
Fig. 3.8 C, the increase of mEPSCs at 5 min is (20-16)/16=25%, the increase of mEPSCs at 20 min is (24-
16)/16=50%. The increase in number of AMPARs is from Fig. 3.12. 
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3.3.5 Synaptic insertion (not lateral diffusion) contributes to synaptic AMPARs increase 
after cLTP:  
It is clear that the new insertion of AMPAR happens after LTP 32,34,38–42. However, it is 
unclear whether the insertion is at synaptic or extrasynaptic region 40. Here, for both GluA1 and 
GluA2, synaptic and extrasynaptic insertion sites after cLTP are found (Fig. 3.13). These insertion 
sites are determined by calculating the distance between the center of Homer1c (synapses) and the 
newly inserted AMPARs at 5 min and 20 min after cLTP for both GluA1- and GluA2-type 
AMPARs (Fig. 3.13). The ratio between synaptic and extrasynaptic population is roughly 3:7 at 5 
min after cLTP (34:66 for GluA1, Fig. 3.13 A; 32:68 for GluA2, Fig. 3.13 B). This measurement 
confirms that the insertion of AMPARs due to cLTP is majorly (70%) extrasynaptic, with a small 
portion (30%) being synaptic.  
As cLTP develops from 5 min post-cLTP to 20 min post-cLTP, there is an increase in the 
synaptic portion of both GluA1 (14% more) and GluA2 (18% more) (Fig. 3.13 C and D). This 
increase could have three pathways (Fig. 3.14): (1) Indirect insertion (avoiding PSD) at synaptic 
region by AMPAR exocytosis; (2) Direct insertion at synaptic region by AMPAR exocytosis; (3) 
Exchange between AMPARs on the surface between extrasynaptic and synaptic site, which 
involves “lateral movement”. Here we want to differentiate pathway 3 from pathway 1 and 2 and 
then speculate between pathways 1 and 2. 
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Figure 3.13 Frequency count histogram of the distance between inserted AMPARs and synapses (center of 
Homer1c) at 5 min and 20 min. X axis is the distance, Y axis is the normalized frequency count. (A) 34% of inserted 
GluA1 are synaptic, 66% are extrasynaptic at 5 min after cLTP. (B) 32% of inserted GluA2 are synaptic, 68% are 
extrasynaptic at 5 min after cLTP. (C) 48% of inserted GluA1 are synaptic, 52% are extrasynaptic at 20 min after 
cLTP. (D) 50% if inserted GluA2 are synaptic, 50% are extrasynaptic at 20 min after cLTP. 
 
Figure 3.14 Three possible pathways for synaptic AMPAR increase from 5 to 20 min after inducing cLTP (1) 
Indirect insertion (avoid PSD) at synaptic region by exocytosis of AMPARs; (2) Direct insertion at synaptic region 
by exocytosis of AMPARs; (3) Lateral diffusion between extrasynaptic and synaptic AMPARs 
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In order to tell whether lateral diffusion (pathway 3) contributes to the increase in synaptic 
AMPARs, the location of the same AMPAR at 5 and 20 min after inducing cLTP is tracked here 
(Fig. 3.15). Distance between the same AMPAR and synapses (the average position of Homer1c) 
is calculated at 5 min and 20 min (Fig. 3.15 A and C). For GluA1, of the total 94 GluA1, there are 
10 GluA1 moving from synaptic to extrasynaptic region, and 7 moving from extrasynaptic to 
synaptic region (Fig. 3.15 B). The net change is 3 (out of 94) GluA1 moving from synaptic to 
extrasynaptic region. This is not significant to change the synaptic GluA1. (Notice that the change 
detected here is due to synaptic to extrasynaptic, the opposite direction one would normally expect 
due to cLTP. This is further evidence that this is not significant). Similarly, for GluA2, out of 146 
GluA2, there are 14 GluA2 moving from synaptic to extrasynaptic region, and 14 moving from 
extrasynaptic to synaptic region (Fig. 3.15 C and D). In this case, the net change is 0 (out of 146). 
This also does not increase synaptic GluA2 population. Taken together, this suggests that the 
lateral diffusion between synaptic and extrasynaptic AMPAR is not the reason for the increase in 
synaptic AMPARs. Therefore, the major source for the increase in synaptic portion from 5 min to 
20 min after cLTP could be pathway 1 or 2. 
 
Figure 3.15 Exchange between synaptic and extrasynaptic AMPARs does not significantly change the synaptic 
portion. X axis is the two time points 5 min and 20 min after cLTP. Y axis is the distance between receptors and 
center of Homer1c (synapse). The two ends of an arrow stand for the distance from Homer1c to the same receptor at 
5 min and 20 min post-cLTP, it shows the moving direction of a receptor. Distance 0~0.5 µm is synaptic, otherwise 
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Figure 3.15 (cont.) is extrasynaptic. (A) Distance between GluA1 and synapses at 5 min and 20 min after cLTP. (B) 
Traces extracted from (A). Those are the GluA1 move from synaptic to extrasynaptic region (red), or the other way 
around (green). Combining A and B, out of 94 GluA1, there are 10 moving from synaptic to extrasynaptic region, 
and 7 moving from extrasynaptic to synaptic region. (C) Distance between GluA2 and synapses at 5 min and 20 min 
after cLTP. (D) Traces extracted from (C). Those are the GluA2 move from synaptic to extrasynaptic region (red), 
or the other way around (green). Combining C and D, out of 146 GluA2, there are 14 GluA2 moving from synaptic 
to extrasynaptic region, and 14 moving from extrasynaptic to synaptic region. 
 
For pathway 1 and 2, we do not have direct evidence to differentiate between them but we 
prefer pathway 1. The reason is because PSD is a compact region with high density of proteins. It 
would therefore be hard for AMPARs to diffuse through. As a result, we think pathway 1 is more 
likely to be the source for synaptic AMPAR increase from 5 to 20 min after inducing cLTP. 
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CHAPTER 4: CONCLUSION 
Human brain has about 80-100 billion of neurons connected with each other by synapses. 
There are 1000-10,000 synapses connecting one neuron to another one. These synapses are 
composed of a pre-synapse from one neuron, a synaptic cleft between the neurons, and a post-
synapse from another neuron. The synapses are moldable, or “plastic” depending on their past 
history. The basal condition is when there is no synaptic strength change. They can also become 
stronger, which is the potentiated condition, when learning and memory formation happens. 
NMDAR and AMPAR are two important glutamate receptors on the postsynaptic membrane. 
Their location and dynamics play crucial roles in maintenance of neuronal health, learning and 
memory formation. They are therefore studied in this work. Atto647N (~4 nm in diameter after 
conjugated to functional groups) is used to label and study those receptors because it is shown to 
have better access than bQDs (> 20 nm in diameter after conjugation) to AMPAR and NMDAR 
inside the synaptic cleft. The reason is because bQDs are too big to enter the synaptic cleft, which 
is 20-25 nm in width.  
Under basal condition, AMPARs are largely in constrained synaptic nanodomains 16. The 
extrasynaptic AMPARs are minor and freely diffusing. This general viewpoint argues against the 
prevailing ‘slots’ hypothesis for AMPARs 61 , in which a sizable pool of AMPAR is waiting just 
outside the synapse until a slot can open up. This ‘slots’ hypothesis, however, is mistaken because 
it relies on looking at AMPARs that are attached with bQDs. The bQDs make it such that AMPAR 
normally cannot go into the synapse. In contrast, we find AMPAR labeled with a small organic 
fluorophore readily goes in, and in fact, has only 23% of AMPAR receptors extrasynaptic. The 
source of synaptic AMPAR is the well-known synaptic pool 16.  
NMDARs are also majorly synaptic and in the nanodomain. However, NMDARs also have 
extrasynaptic nanodomains, and this is different from AMPARs. The extrasynaptic nanodomains 
of NMDARs are found with either bQDs or Atto647N, which means the extrasynaptic 
nanodomains is not an artifact of the bQDs. And the extrasynaptic nanodomain of NMDARs might 
be significant in regulating the NMDARs during LTP or maturation. 
Maturation is an important process under basal condition. The two subunits of NMDAR, 
GluN2A and GluN2B are thought to be important in maturation because of the changes in their 
numbers during neuronal maturation. Therefore, we looked at the location and movement of these 
two sub-types during maturation to understand how the localization and diffusion of GluN2A and 
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GluN2B change during maturation. We compare the diffusion coefficients in premature and 
mature neurons for GluN2A and GluN2B. We find both GluN2A and GluN2B diffuse 2x slower 
as neurons become mature with different mechanisms. GluN2A becomes slower because there is 
an increase in slow GluN2A population and decrease in slow GluN2A diffusion rates. GluN2B 
becomes slower because there is an increase in slow GluN2B population and decrease in fast 
GluN2B diffusion rates. Meanwhile, there are also redistribution of the two subunits between 
extrasynaptic region and synaptic region. Those observations emphasize the important, though 
distinct, roles of GluN2A and GluN2B during maturation process.  
In mature neurons, the synaptic and extrasynaptic NMDARs are important in neuronal 
function and dysfunction. We quantified the synaptic/extrasynaptic for both GluN2A and GluN2B. 
We find 13% more synaptic portion for GluN2A than GluN2B in our measurements. This suggests 
different roles of these two subunits in the maintenance of neuronal health. 
Under cLTP condition (induced by glycine), NMDARs can be activated and cause insertion 
of AMPARs on the postsynaptic membrane. We find majority of AMPARs are inserted in 
extrasynaptic sites, which has been shown in many publications 34,39–42. Beyond that, it also finds 
a small group of AMPARs inserted in the synaptic sites, which have not been shown previously.  
As cLTP develops from 5 min to 20 min, we observe increase in synaptic AMPAR 
population. We find the synaptic insertion, not lateral diffusion from extrasynaptic region, 
contributes to the increasing the number of synaptic AMPARs, which can cause potentiation in 
mEPSCs, and eventually leads to cLTP. The synaptic insertion could happen directly at PSD or 
avoiding PSD and then exocytosis, we do not have evidence in terms of which is the actual pathway. 
However, since PSD is a compacted region, we therefore predict that the synaptic insertion of 
AMPARs would avoid PSD and then exocytosis. 
This work also shows structure change AMPAR happens during cLTP. It finds that the 
increase in surface AMPARs reduces at late stage of cLTP compared to early stage. However, this 
small increase in AMPAR numbers causes big increase in currents. This means the current flow 
through AMPAR channel is increasing to compensate for the reduced increase in AMPAR 
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